Feature Channels:

OBGYN

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Researchers Discover Key to Drug Resistance in Common Breast Cancer Treatment

nettles_kendall.jpg

Scientists from the Florida campus of The Scripps Research Institute (TSRI), the University of California (UC), San Diego and the University of Illinois have found that two immune system molecules may be key to the development of drug resistance in estrogen-driven breast cancers.

Medicine

Channels:

Focused Ultrasound, Breast, breast fibroadenoma, Breast Tumor

Pivotal Trial Begins for Breast Fibroadenoma Using Focused Ultrasound

FUSBreninRochman_23.JPG

Patients with benign breast tumors may be eligible for a new focused ultrasound–based investigational treatment as part of a pivotal, multi-center clinical study. The trial began last month at the University of Virginia (UVA) Medical Center.

Medicine

Channels:

NCCN, Yale Cancer Center, Racial Disparities, Breast Cancer

Yale Study Published in JNCCN Uncovers Racial Disparities in Treatment of Women with Breast Cancer

jnccn.jpg

The study, “Racial and Ethnic Disparities in Oncotype Dx™ Test Receipt in a State-Wide Population-Based Study,” led by Cary P. Gross, MD, Yale University School of Medicine and a member of Yale Cancer Center, is published in the March issue of JNCCN – Journal of the National Comprehensive Cancer Network.

Medicine

Channels:

Tulane University School of Medicine, Estrogen, Menopausal Hormone Therapy, Hormone Replacement Therapy, Estrogen Receptor

Tulane Researcher Awarded $1.9 Million to Improve Menopausal Hormone Therapy

031517_sarah-lindsey800_6684_pbc.jpeg

New research at the Tulane University School of Medicine is looking at an estrogen receptor that could be a site for targeted hormone replacement therapy in post-menopausal women.

Medicine

Channels:

Prostate, Prostate Cancer, clinical trial, Prostate Cancer Treatment, Radiation, Radiation Therapy, Radiation Treatment, men and cancer, princess margaret cancer centre, University Health Network

Prostate Cancer Clinical Trial Shows Treating with Precision Radiotherapy Reduces Course of Treatment by 50%

Dr.CharlesCatton.jpg

An Ontario-led international clinical trial with 1,206 men with localized prostate cancer shows that compressing radiation treatments into four weeks from eight delivers similar outcomes.

Medicine

Channels:

Phthalates, Pregnancy, Hormones, Plastics, Endocrinology, Endocrine Disrupting Chemicals, fetal exposure to diethylhexyl phthalate, genital abnormalities, Reproductive Health, Estrogen, Babies, Vinyl

Study Links Exposure to Common Chemicals During Early Pregnancy to Altered Hormone Levels in Fetus

Food is the most likely source of exposure to the most harmful phthalates, which can also be found in household and personal care products.Exposure during early pregnancy to some phthalates—man-made chemicals commonly found in household plastics, food and personal care products—can have adverse impacts on developing fetuses, according to a new study led by Dr.

Medicine

Channels:

NCCN, Personalized Medicine, oncotype dx, Genetic Mutation, Genetic Expression, jnccn, JNCCN - Journal of the National Comprehensive Cancer Network, Cancer, Oncology, Breast Cancer, Patient Access, Yale Cancer Center

Yale Study Published in JNCCN Uncovers Racial Disparities in Treatment of Women with Breast Cancer

CGross_Headshot_0317.jpg

Researchers at Yale Cancer Center/Smilow Cancer Hospital found that black and Hispanic women in Connecticut are significantly less likely to undergo gene expression profiling than white women.

Medicine

Channels:

Labor & Delivery, Cesarean Section, C Section, IV fluids

More IV Fluids, Fewer C-Sections

By pooling the data of several studies, Thomas Jefferson University researchers showed that a higher rate of IV fluids not only decreased C-section rates, but also shortened the overall length of labor by one hour, as well as shortened the pushing phase. The results were published online as an accepted article in Acta Obstetricia et Gynecologica Scandinavica.

Science

Channels:

Study Finds No Benefit, but Possible Harm, From Drug Used to Prevent Preterm Births

nelson-mcintire.jpg

A drug commonly prescribed to pregnant women with a history of delivering babies early provides no benefit. In fact, this drug may even increase the risk of developing gestational diabetes.

Medicine

Channels:

Breast Cancer, Radiation Therapy, Lumpectomy

Reducing Radiation Could Safely Cut Breast Cancer Treatment Costs

More than half of older women with early stage breast cancer received more radiation therapy than what might be medically necessary, adding additional treatment and health care costs, according to a study led by Duke Cancer Institute researchers.







Chat now!